Clinical Trials on Ovarian Cancer (Epithelial)
Total 65765 results
-
Hospital Clinic of BarcelonaRecruitingAdvanced Ovarian CancerSpain
-
Xinhua Hospital, Shanghai Jiao Tong University...WithdrawnPlatinum-resistant Ovarian CancerChina
-
AstraZenecaCompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Canada
-
The Affiliated Hospital of Qingdao UniversityCompletedHigh-Grade Serous Ovarian CancerChina
-
PsiOxus Therapeutics LtdCompletedRecurrent Platinum Resistant Ovarian CancerUnited Kingdom, Spain
-
Jihong LiuUnknownPlatinum-resistant Ovarian CancerChina
-
Centre Francois BaclesseARCAGY/ GINECO GROUP; French Cancer Research Hospital ProgramCompletedPlatinum-resistant or Refractory Ovarian CancerFrance
-
AGC Biologics S.p.A.CompletedOvarian Cancer Metastatic RecurrentItaly
-
PharmaMar, SpainCompleted
-
AccentureCompletedRecurrent Platinum-resistant Ovarian CancerAustralia, Russian Federation, United Kingdom
-
AstraZenecaMyriad Genetic Laboratories, Inc.WithdrawnPlatinum Sensitive Relapsed Ovarian CancerUnited States, Korea, Republic of, Peru, United Kingdom, Philippines
-
COL George Peoples, MD, FACSCompletedOvarian Cancer | Endometrial Cancer | Peritoneal Cancer | Fallopian CancerUnited States
-
Biocity Biopharmaceutics Co., Ltd.Not yet recruitingAdvanced Ovarian Cancer | Serous Ovarian Cancer
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingFallopian Tube Cancer | Solid Tumor | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Australia, Bosnia and Herzegovina, Bulgaria, Georgia, Korea, Republic of, Serbia
-
Yale UniversityNational Cancer Institute (NCI)TerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Recurrent Ovarian Germ Cell TumorUnited States
-
Genelux CorporationGOG FoundationRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Platinum-refractory Ovarian Cancer | Primary Peritoneal Cancer | High-grade Serous Ovarian Cancer | Endometrioid Ovarian Cancer | Ovarian Clear Cell CarcinomaUnited States
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT)Active, not recruitingOvarian Neoplasms | Ovarian, Fallopian Tube and Primary Peritoneal CarcinomaUnited States, Netherlands, Spain, Finland, Italy, Poland, Belgium, Canada, France, Germany, Romania, Ukraine, Norway, United Kingdom, Israel, Greece, Denmark, Belarus, Czechia
-
Royal Surrey County Hospital NHS Foundation TrustRecruitingFallopian Tube Neoplasms | Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Ovarian Neoplasm | Ovarian Neoplasm EpithelialUnited Kingdom
-
zr Pharma & GmbHCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer | Other Solid Tumor | Metastatic Castration-Resistant Prostate CancerIsrael, Italy, Canada, Russian Federation, United Kingdom, Poland
-
ImunonActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States, Canada
-
The Affiliated Hospital of the Chinese Academy...Recruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Uppsala University HospitalUppsala University; The Netherlands Cancer InstituteRecruitingOvarian Cancer RecurrentSweden
-
Zai Lab (Shanghai) Co., Ltd.Active, not recruitingPlatinum-sensitive Relapsed Ovarian CancerChina
-
Ayana Pharma Ltd.,Lambda Therapeutic Research Ltd.CompletedOvarian Cancer RecurrentIndia
-
ARCAGY/ GINECO GROUPCompletedOvarian Cancer RecurrentFrance
-
Leiden University Medical CenterUniversity Medical Center GroningenCompletedRecurrent Ovarian CancerNetherlands
-
Wuhan UniversityUnknown
-
Elucida OncologyRecruitingOvarian Diseases | Ovarian Neoplasms | Ovarian Cancer | Ovarian Epithelial Cancer | Fallopian Tube Cancer | Endometrial Neoplasms | Endometrial Cancer | Endometrial Clear Cell Adenocarcinoma | Ovarian Carcinoma | Endometrial Adenocarcinoma | Peritoneal Cancer | Endometrioid Adenocarcinoma | Ovarian Adenocarcinoma | Ovarian Serous Adenocarcinoma and other conditionsUnited States
-
Gynaecologisch Oncologisch Centrum ZuidRadboud University Medical Center; Maastricht University Medical Center; Erasmus... and other collaboratorsRecruitingRecurrent Ovarian Cancer | Therapy-Associated Cancer | Signal Transduction Pathway DeregulationNetherlands
-
University of ChicagoNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube CancerUnited States
-
Eve RodlerNot yet recruitingBreast Cancer | Ovarian Cancer | Breast Neoplasm | Breast Carcinoma | Breast Cancer Stage IV | Breast Cancer Stage I | Breast Cancer Stage II | Invasive Breast Cancer | Cancer, Breast | Breast Cancer Stage III | Ovary Cancer | Malignant Tumor of Breast | Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IV | Ovarian Cancer... and other conditionsUnited States
-
Cristal TherapeuticsCompletedCancer | Ovarian CancerNetherlands, Belgium, United Kingdom
-
University of OklahomaVerastem, Inc.RecruitingCervical Cancer | Solid Tumor | Endometrioid Cancer | Mucinous Ovarian Cancer | High Grade Serous Ovarian CancerUnited States
-
Seoul National University HospitalRecruitingFallopian Tube Cancer | Peritoneal Cancer | Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IVKorea, Republic of
-
Syndax PharmaceuticalsPfizer; Merck KGaA, Darmstadt, GermanyCompletedStudy of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian CancerFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States
-
ImunonCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States
-
Fudan UniversityNot yet recruitingRecurrent Ovarian CancerChina
-
Women's Hospital School Of Medicine Zhejiang UniversityRecruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRecurrent Platinum-resistant Ovarian CancerChina
-
Marker Therapeutics, Inc.TerminatedOvarian Cancer | Platinum Sensitive Ovarian CancerUnited States
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.CompletedNon-Germline BRCA Mutated Ovarian CancerItaly, Spain, Sweden, Canada, Czechia, Poland, United Kingdom, Israel, Austria, Belgium, Switzerland, Netherlands, Bulgaria, Finland, Norway, Denmark, Slovenia, Portugal
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Ovarian CancerChina
-
AstraZenecaNo longer availablePSR Ovarian Cancer With a BRCA MutationJapan
-
Mateon TherapeuticsTerminatedPlatinum Resistant Ovarian CancerUnited States, Belgium, Germany
-
Esperance Pharmaceuticals IncCompletedOvarian Cancer RecurrentUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Stage IIA Fallopian Tube Cancer | Stage IIA Ovarian Cancer | Stage IIB Fallopian Tube Cancer | Stage IIB Ovarian Cancer | Stage IIC Fallopian Tube Cancer | Stage IIC Ovarian Cancer | Stage IIIA Fallopian... and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)WithdrawnStage IIIA Fallopian Tube Cancer | Stage IIIA Ovarian Cancer | Stage IIIA Primary Peritoneal Cancer | Stage IIIB Fallopian Tube Cancer | Stage IIIB Ovarian Cancer | Stage IIIB Primary Peritoneal Cancer | Stage IIIC Fallopian Tube Cancer | Stage IIIC Ovarian Cancer | Stage IIIC Primary Peritoneal Cancer and other conditions